Abstract
Background: Intra-operative PTH testing in the operating theatre has proven to be an accurate way to verify the removal of all pathological parathyroid tissue in primary hyperparathyroidism. Its limitation is the high cost. An alternative, more cost-effective procedure is proposed: intra-operative PTH dosage at the Central Laboratory. Patients and methods: Fifty-four patients underwent parathyroidectomy with intraoperative dosage of PTH at the Central Laboratory. Three blood samples were taken from each patient: just after the induction of anesthesia, 5 and 10 min after parathyroidectomy. The samples were sent to the Central Laboratory and analysed simultaneously. The results were phoned back to the theatre. The procedure was considered effective when PTH drop was ≥50% from basal value, 10 min after parathyroidectomy. Results: 98.1% of patients proved recovered (average follow-up 31.1 months). The procedure had 3 false negatives, 1 false positive, with sensitivity, specificity, accuracy, positive predictive value and negative predictive value of 94.0%, 75.0%, 92.6%, 97.9%, and 50.0%, respectively. Discussion and conclusion: The main disadvantage of the presented procedure is the long waiting time. Nevertheless this time is the same as that required for results from intra-operative histological examination, the only alternative to determine surgery effectiveness in centres where portable instrumentation for intra-operative PTH dosage in the operating theatre is not available. The advantage of intra-operative PTH at the Central Laboratory is the very low cost. If results in terms of sensitivity, specificity, accuracy, and cost are taken into consideration, intra-operative dosage of PTH at the Central Laboratory may be deemed a viable alternative to the operating theatre.
Similar content being viewed by others
References
Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005, 132: 359–72.
De Groot LJ, Jameson JL. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co. 2001.
Clark OH. Surgical treatment of primary hyperparathyroidism. Adv Endocrinol Metab 1995, 6: 1–16.
Irvin GL 3rd, Dembrow VD, Prudhomme DL. Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery 1993, 114: 1019–23.
Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang C. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 1988, 104: 1121–7.
Miccoli P, Pinchera A, Cecchini G, et al. Minimally invasive video-assisted parathyroid surgery for primary hyperparathyroidism. J Endocrinol Invest 1997, 20: 429–30.
Naitoh T, Gagner M, Garcia-Ruiz A, Heniford BT. Endoscopic endocrine surgery in the neck. An initial report of endoscopic sub-total parathyroidectomy. Surg Endosc 1998, 12: 202–5.
Carter AB, Howanitz PJ. Intraoperative testing for parathyroid hormone. A comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 2003, 127: 1424–42.
Irvin GL, Carneiro DM. Rapid parathyroid hormone assay guided exploration. Operative Tech Gen Surg 1999, 1: 18–27.
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 2003, 134: 973–81.
Irvin GL 3rd, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 2004, 28: 1287–92.
Libutti SK, Alexander HR, Bartlett DL, et al. Kinetic analysis of the rapid intraoperative assay in patients during operation for hyperparathyroidism. Surgery 1999, 126: 1145–51.
Mengozzi G, Baldi C, Aimo G, et al. Optimizing efficay of quick parathyroid hormone determination in the operative theatre. Int J Biol Markers 2000, 15: 153–60.
Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 2002, 137: 659–69.
Mandell DL, Genden EM, Mechanick JL, Bergman DA, Diamond EJ, Urken ML. The influence of intraoperative parathyroid hormone monitoring on the surgical management of hyperparathyroidism. Arch Otolaryngol Head Neck Surg 2001, 127: 821–7.
Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearence as measured by three rapid immunoassays during parathyroidectomy. Clin Chem 2002, 48: 1731–8.
Chou FF, Lee CH, Chen JB, Hsu KT, Sheen-Chen SM. Intraoperative parathyyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 2002, 137: 341–4.
Vignali E, Picone A, Materazzi G, et al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primari hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrol 2002, 146: 783–8.
Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of frozen section. Am J Pathol 1998, 22: 538–44.
Heath H 3rd, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980, 302: 189–93.
Carneiro DM, Irvin GL 3rd. New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy. World J Surg 2002, 26: 1074–7.
Hortin GL, Carter AB; College of American Pathologists Point-of-Care Testing Resource Committee. Intraoperative parathyroid hormone testing: survey of testing program characteristics. Arch Pathol Lab Med 2002, 126: 1045–9.
Sokoll LJ, Wians FH Jr, Remaley AT. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin Chem 2004, 50: 1126–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Pasquale, L., Gobatti, D., Ravini, M.L. et al. Intra-operative testing for parathyroid hormone: the Central Laboratory option. J Endocrinol Invest 31, 62–67 (2008). https://doi.org/10.1007/BF03345568
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345568